vs

Side-by-side financial comparison of AMERICAN SHARED HOSPITAL SERVICES (AMS) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.

Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $7.7M, roughly 1.9× AMERICAN SHARED HOSPITAL SERVICES). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -8.2%, a 72.4% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -14.8%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-2.7M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 21.7%).

American Shared Hospital Services offers turnkey outsourced solutions for advanced radiotherapy, stereotactic radiosurgery and diagnostic imaging equipment to healthcare facilities. It eliminates high upfront capital costs for hospitals, operates primarily across North America, and also serves Latin America and select Asia-Pacific markets, catering to both public and private hospital segments.

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

AMS vs IDR — Head-to-Head

Bigger by revenue
IDR
IDR
1.9× larger
IDR
$14.6M
$7.7M
AMS
Growing faster (revenue YoY)
IDR
IDR
+106.8% gap
IDR
92.0%
-14.8%
AMS
Higher net margin
IDR
IDR
72.4% more per $
IDR
64.3%
-8.2%
AMS
More free cash flow
IDR
IDR
$10.8M more FCF
IDR
$8.2M
$-2.7M
AMS
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
21.7%
AMS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMS
AMS
IDR
IDR
Revenue
$7.7M
$14.6M
Net Profit
$-631.0K
$9.4M
Gross Margin
11.7%
68.5%
Operating Margin
-18.1%
62.4%
Net Margin
-8.2%
64.3%
Revenue YoY
-14.8%
92.0%
Net Profit YoY
52.5%
220.6%
EPS (diluted)
$-0.09
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMS
AMS
IDR
IDR
Q4 25
$7.7M
$14.6M
Q3 25
$7.2M
$11.1M
Q2 25
$7.1M
$9.5M
Q1 25
$6.1M
$7.3M
Q4 24
$9.1M
$7.6M
Q3 24
$7.0M
$6.2M
Q2 24
$7.1M
$6.1M
Q1 24
$5.2M
$5.9M
Net Profit
AMS
AMS
IDR
IDR
Q4 25
$-631.0K
$9.4M
Q3 25
$-17.0K
$3.0M
Q2 25
$-280.0K
$2.8M
Q1 25
$-625.0K
$1.6M
Q4 24
$-1.3M
$2.9M
Q3 24
$-207.0K
$1.6M
Q2 24
$3.6M
$2.2M
Q1 24
$119.0K
$2.2M
Gross Margin
AMS
AMS
IDR
IDR
Q4 25
11.7%
68.5%
Q3 25
22.1%
63.6%
Q2 25
23.1%
57.8%
Q1 25
15.4%
50.8%
Q4 24
35.3%
53.3%
Q3 24
19.6%
48.7%
Q2 24
35.0%
50.2%
Q1 24
41.1%
48.1%
Operating Margin
AMS
AMS
IDR
IDR
Q4 25
-18.1%
62.4%
Q3 25
-4.8%
23.4%
Q2 25
-7.7%
26.6%
Q1 25
-21.3%
19.3%
Q4 24
-20.2%
36.2%
Q3 24
-12.7%
23.4%
Q2 24
-0.0%
34.2%
Q1 24
-1.6%
36.3%
Net Margin
AMS
AMS
IDR
IDR
Q4 25
-8.2%
64.3%
Q3 25
-0.2%
26.8%
Q2 25
-4.0%
29.2%
Q1 25
-10.2%
22.1%
Q4 24
-14.6%
38.5%
Q3 24
-3.0%
25.8%
Q2 24
51.0%
35.2%
Q1 24
2.3%
36.8%
EPS (diluted)
AMS
AMS
IDR
IDR
Q4 25
$-0.09
$0.62
Q3 25
$0.00
$0.20
Q2 25
$-0.04
$0.20
Q1 25
$-0.10
$0.12
Q4 24
$-0.21
$0.21
Q3 24
$-0.03
$0.12
Q2 24
$0.55
$0.17
Q1 24
$0.02
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMS
AMS
IDR
IDR
Cash + ST InvestmentsLiquidity on hand
$3.5M
Total DebtLower is stronger
$17.4M
$2.3M
Stockholders' EquityBook value
$24.0M
$108.2M
Total Assets
$55.5M
$116.2M
Debt / EquityLower = less leverage
0.72×
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMS
AMS
IDR
IDR
Q4 25
$3.5M
Q3 25
$5.1M
Q2 25
$11.1M
Q1 25
$11.2M
Q4 24
$11.0M
Q3 24
$13.8M
Q2 24
$14.2M
$6.3M
Q1 24
$12.8M
$5.3M
Total Debt
AMS
AMS
IDR
IDR
Q4 25
$17.4M
$2.3M
Q3 25
$18.2M
$3.0M
Q2 25
$19.1M
$3.3M
Q1 25
$19.9M
$3.7M
Q4 24
$20.4M
$1.7M
Q3 24
$14.4M
$2.9M
Q2 24
$15.1M
$2.7M
Q1 24
$15.6M
$3.3M
Stockholders' Equity
AMS
AMS
IDR
IDR
Q4 25
$24.0M
$108.2M
Q3 25
$24.6M
$74.3M
Q2 25
$24.5M
$49.3M
Q1 25
$24.6M
$39.8M
Q4 24
$25.2M
$37.7M
Q3 24
$26.4M
$33.1M
Q2 24
$26.5M
$25.4M
Q1 24
$22.8M
$21.6M
Total Assets
AMS
AMS
IDR
IDR
Q4 25
$55.5M
$116.2M
Q3 25
$59.6M
$83.1M
Q2 25
$63.5M
$57.7M
Q1 25
$63.3M
$48.1M
Q4 24
$60.2M
$44.0M
Q3 24
$63.3M
$40.8M
Q2 24
$60.8M
$32.2M
Q1 24
$50.1M
$28.7M
Debt / Equity
AMS
AMS
IDR
IDR
Q4 25
0.72×
0.02×
Q3 25
0.74×
0.04×
Q2 25
0.78×
0.07×
Q1 25
0.81×
0.09×
Q4 24
0.81×
0.05×
Q3 24
0.54×
0.09×
Q2 24
0.57×
0.11×
Q1 24
0.68×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMS
AMS
IDR
IDR
Operating Cash FlowLast quarter
$-704.0K
$10.7M
Free Cash FlowOCF − Capex
$-2.7M
$8.2M
FCF MarginFCF / Revenue
-34.8%
56.0%
Capex IntensityCapex / Revenue
25.7%
17.7%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$-8.5M
$12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMS
AMS
IDR
IDR
Q4 25
$-704.0K
$10.7M
Q3 25
$1.7M
$2.4M
Q2 25
$-372.0K
$3.5M
Q1 25
$2.5M
$2.4M
Q4 24
$274.0K
$3.2M
Q3 24
$472.0K
$2.5M
Q2 24
$1.3M
$2.6M
Q1 24
$-1.9M
$2.6M
Free Cash Flow
AMS
AMS
IDR
IDR
Q4 25
$-2.7M
$8.2M
Q3 25
$-2.0M
$709.8K
Q2 25
$-2.3M
$2.5M
Q1 25
$-1.5M
$1.0M
Q4 24
$-4.4M
$2.1M
Q3 24
$-407.0K
$1.9M
Q2 24
$70.0K
$2.4M
Q1 24
$-3.0M
$2.3M
FCF Margin
AMS
AMS
IDR
IDR
Q4 25
-34.8%
56.0%
Q3 25
-28.3%
6.4%
Q2 25
-32.1%
26.5%
Q1 25
-24.7%
13.8%
Q4 24
-48.4%
28.0%
Q3 24
-5.8%
30.4%
Q2 24
1.0%
38.7%
Q1 24
-58.4%
38.3%
Capex Intensity
AMS
AMS
IDR
IDR
Q4 25
25.7%
17.7%
Q3 25
51.6%
15.3%
Q2 25
26.9%
10.8%
Q1 25
65.7%
19.4%
Q4 24
51.4%
13.6%
Q3 24
12.6%
9.8%
Q2 24
17.2%
4.3%
Q1 24
22.7%
5.5%
Cash Conversion
AMS
AMS
IDR
IDR
Q4 25
1.15×
Q3 25
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
1.08×
Q3 24
1.56×
Q2 24
0.36×
1.22×
Q1 24
-15.67×
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMS
AMS

Direct Patient Services$4.0M51%
Rental Income From Medical Services$2.7M35%
Pbrt Services$1.2M15%

IDR
IDR

Segment breakdown not available.

Related Comparisons